The DOI matches its Crossref record; 248 of the 248 references it cites were found in a registry or an index.
Endocrine disrupters as obesogens
Open accessAbstract
The recent dramatic rise in obesity rates is an alarming global health trend that consumes an ever increasing portion of health care budgets in Western countries. The root cause of obesity is thought to be a prolonged positive energy balance. Hence, the major focus of preventative programs for obesity has been to target overeating and inadequate physical exercise. Recent research implicates environmental risk factors, including nutrient quality, stress, fetal environment and pharmaceutical or chemical exposure as relevant contributing influences. Evidence points to endocrine disrupting chemicals that interfere with the body's adipose tissue biology, endocrine hormone systems or central hypothalamic-pituitary-adrenal axis as suspects in derailing the homeostatic mechanisms important to weight control. This review highlights recent advances in our understanding of the molecular targets and mechanisms of action for these compounds and areas of future research needed to evaluate the significance of their contribution to obesity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–248 of 248
Gazzerro, P., Caruso, M. G., Notarnicola, M., Misciagna, G., Guerra, V., Laezza, C., & Bifulco, M. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803510 · Cited by 76
Glycyrrhizic acid: the assessment of a no effect level
van Gelderen, C. E. M., Bijlsma, J. A., Dokkum, W. V., & Savelkoull, T. J. F. (2000) · Human & Experimental Toxicology · doi:10.1191/096032700682694251 · Cited by 75
Moreno-Aliaga, M. J., & Matsumura, F. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00933-9 · Cited by 72
Di-n-butyl-and Di-2-ethylhexyl phthalate in human adipose tissue
Mes, J., Coffin, D. E., & Campbell, D. S. (1974) · Bulletin of Environmental Contamination and Toxicology · doi:10.1007/bf01685921 · Cited by 72
Nakano, R., Kurosaki, E., Yoshida, S., Yokono, M., Shimaya, A., Maruyama, T., & Shibasaki, M. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.03.023 · Cited by 71
Blood levels of organotin compounds and their relation to fish consumption in Finland
Rantakokko, P., Turunen, A. W., Verkasalo, P. K., Kiviranta, H., Männistö, S., & Vartiainen, T. (2008) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2008.03.017 · Cited by 68
Tsumura, Y., ISHIMITSU, S., Saito, I., Sakai§, H., Tsuchida§, Y., & TONOGAI, Y. (2003) · Food Additives & Contaminants · doi:10.1080/0265203031000122021 · Cited by 66
Usual dietary isoflavone intake and body composition in postmenopausal women
Goodman‐Gruen, D., & Kritz‐Silverstein, D. C. (2003) · Menopause The Journal of The North American Menopause Society · doi:10.1097/01.gme.0000058866.35869.b4 · Cited by 65
Antenatal Exposure to DES: Lessons Learned … Future Concerns
Rubin, M. M. (2007) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000271138.31234.d7 · Cited by 65
Gastric estrogen directly induces ghrelin expression and production in the rat stomach
Sakata, I., Tanaka, T., Yamazaki, M., Tanizaki, T., Zhao, Z., & Sakai, T. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06808 · Cited by 65
Posnack, N. G., Lee, N. H., Brown, R. P., & Sarvazyan, N. A. (2010) · Toxicology · doi:10.1016/j.tox.2010.09.007 · Cited by 62
Daily intakes of tributyltin and triphenyltin compounds from meals.
Tsuda, T., Inoue, T., Kojima, M., & Aoki, S. (1995) · PubMed · Cited by 61
Martínez-Hernández, A., Enríquez, L. H. G., Moreno-Aliaga, M. J., & Martí, A. (2007) · Public Health Nutrition · doi:10.1017/s1368980007000626 · Cited by 59
Uncoupling protein 1 and 3 polymorphisms are associated with waist-to-hip ratio
Herrmann, S.-M., Wang, J., Staessen, J. A., Kertmen, E., Schmidt‐Petersen, K., Zidek, W., Paul, M., & Brand, E. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0431-1 · Cited by 59
Cooke, G. M., Forsyth, D. S., Bondy, G. S., Tachon, R., Tague, B., & Coady, L. (2008) · Journal of Toxicology and Environmental Health · doi:10.1080/15287390701801653 · Cited by 58
Nishiu, J., Ito, M., Ishida, Y., Kakutani, M., Shibata, T., Matsushita, M., & Shindo, M. (2006) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00536.x · Cited by 56
Xie, Y., Yang, Q., Nelson, B. D., & DePierre, J. W. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00386-1 · Cited by 56
TBTC induces adipocyte differentiation in human bone marrow long term culture
Carfì, M., Croera, C., Ferrario, D., Campi, V., Bowe, G., Pieters, R. H. H., & Gribaldo, L. (2008) · Toxicology · doi:10.1016/j.tox.2008.03.025 · Cited by 52
Yun, A. J., Bazar, K. A., Lee, P. Y., Gerber, A. N., & Daniel, S. M. (2005) · Medical Hypotheses · doi:10.1016/j.mehy.2004.11.040 · Cited by 51
The Metabolic Syndrome During Atypical Antipsychotic Drug Treatment: Mechanisms and Management
Baptista, T., Mendoza, S., Beaulieu, S., Bermúdez, A., & Martinez, M. (2004) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2004.2.290 · Cited by 50
Janer, G., Navarro, J. C., & Porte, C. (2007) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2007.04.009 · Cited by 50
Croutch, C. R., Lebofsky, M., Schramm, K., Terranova, P. F., & Rozman, K. K. (2005) · Toxicological Sciences · doi:10.1093/toxsci/kfi106 · Cited by 50
Activation of AMP-activated protein kinase by tributyltin induces neuronal cell death
Nakatsu, Y., Kotake, Y., Hino, A., & Ohta, S. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.03.021 · Cited by 48
Intraventricular insulin decreases kappa opioid-mediated sucrose intake in rats
Sipols, A. J., Bayer, J., Bennett, R., & Figlewicz, D. P. (2002) · Peptides · doi:10.1016/s0196-9781(02)00246-2 · Cited by 47
Coburn, C. G., Curras-Collazo, M. C., & Kodavanti, P. R. S. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm086 · Cited by 45
Zhao, Z., Sakata, I., Okubo, Y., Koike, K., Kangawa, K., & Sakai, T. (2007) · Journal of Endocrinology · doi:10.1677/joe-07-0300 · Cited by 45
Measurement Error in Epidemiologic Studies
Carroll, R. J. (2005) · Wiley eBooks · doi:10.1002/0470011815.b2a03082 · Cited by 43
Association of UCP3 Gene –55C>T Polymorphism and Obesity in a Spanish Population
Alonso, Á., Martí, A., Corbalán, M. S., Martínez‐González, M. Á., Forga, L., & Martínez, J. A. (2005) · Annals of Nutrition and Metabolism · doi:10.1159/000086883 · Cited by 43
Vermorel, M., Lazzer, S., Bitar, A., Ribeyre, J., Montaurier, C., Fellmann, N., Coudert, J., Meyer, M., & Boirie, Y. (2005) · annales de biologie animale biochimie biophysique · doi:10.1051/rnd:2005014 · Cited by 42
Itsuki, A., Kimoto, M., Tsuji, H., HIEMORI, M., & Yamashita, H. (2007) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.60478 · Cited by 40
Lisboa, P. C., Fagundes, A. T. S., Denolato, A. T. A., Oliveira, E., Bonomo, I. T., Alves, S. B., Curty, F. H., Passos, M. C. F., & de Moura, E. G. (2008) · Experimental Biology and Medicine · doi:10.3181/0705-rm-146 · Cited by 40
Fetissov, S. O., Huang, P., Zhang, Q., Mimura, J., Fujii‐Kuriyama, Y., Rannug, A., Hökfelt, T. G. M., & Ceccatelli, S. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2004.01.009 · Cited by 40
Characterization of the adipose tissue atrophy induced by peroxisome proliferators in mice
Xie, Y., Yang, Q., Nelson, B. D., & DePierre, J. W. (2002) · Lipids · doi:10.1007/s11745-002-0873-7 · Cited by 38
The Effect of Centrally Administered CCK-Receptor Antagonists on Food Intake in Rats
Curcio, M. J., Gibbs, J., & Smith, G. P. (1997) · Physiology & Behavior · doi:10.1016/s0031-9384(96)00561-6 · Cited by 37
Ho, M., Shin, H. D., Kim, K. S., Lee, B. H., & Yoon, Y. (2006) · Metabolism · doi:10.1016/j.metabol.2005.11.012 · Cited by 37
Csaba, G., & Inczefi-Gonda, Á. (1998) · Human & Experimental Toxicology · doi:10.1177/096032719801700203 · Cited by 36
Imprinted Genes, Postnatal Adaptations and Enduring Effects on Energy Homeostasis
Frontera, M., Dickins, B., Plagge, A., & Kelsey, G. (2008) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-77576-0_4 · Cited by 35
Perfluorooctane Sulfonate Influences Feeding Behavior and Gut Motility via the Hypothalamus
Asakawa, A., Toyoshima, M., Fujimiya, M., Harada, K., Ataka, K., Inoue, K., & Koizumi, A. (2007) · International Journal of Molecular Medicine · doi:10.3892/ijmm.19.5.733 · Cited by 33
Cooke, P. S., & Naaz, A. (2005) · Birth Defects Research Part A Clinical and Molecular Teratology · doi:10.1002/bdra.20142 · Cited by 29
Garbrecht, M. R., Krozowski, Z. S., Snyder, J. M., & Schmidt, T. J. (2006) · Steroids · doi:10.1016/j.steroids.2006.06.001 · Cited by 29
Asakawa, A., Toyoshima, M., Harada, K., Fujimiya, M., Inoue, K., & Koizumi, A. (2008) · International Journal of Molecular Medicine · doi:10.3892/ijmm.21.4.439 · Cited by 26 · cited 1×
“This phenotype is not observed in PPAR knockout animals (Asakawa et al., 2008).”
Perinatal Programming of Central Obesity and the Metabolic Syndrome: Role of Glucocorticoids
Achard, V., Boullu‐Ciocca, S., Desbrière, R., & Grino, M. (2006) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2006.4.129 · Cited by 23
Lindén, J., Korkalainen, M., Lensu, S., Tuomisto, J., & Pohjanvirta, R. (2005) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.20065 · Cited by 22
Interaction of DIO2 T92A and PPARγ2 P12A Polymorphisms in the Modulation of Metabolic Syndrome
Fiorito, M., Torrente, I., Cosmo, S. D., Guida, V., Colosimo, A., Prudente, S., Flex, E., Menghini, R., Miccoli, R., Penno, G., et al. (2007) · Obesity · doi:10.1038/oby.2007.343 · Cited by 22
The new clinical trials with thiazolidinediones – DREAM, ADOPT, and CHICAGO: promises fulfilled?
Goldberg, R. B. (2007) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32821f604c · Cited by 22
Cannabinoids in Eating Disorders and Obesity
Árias, F. (2007) · Molecular Neurobiology · doi:10.1007/s12035-007-0018-x · Cited by 18
Variations in the uncoupling protein-3 gene are associated with specific obesity phenotypes
van Abeelen, A. F. M., de Krom, M., Hendriks, J., Grobbee, D. E., Adan, R. A. H., & van der Schouw, Y. T. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0834 · Cited by 15
TBTC reduces lymphocyte population in human bone marrow long-term culture
Carfì, M., Carfì, M., Croera, C., Bowe, G., Pieters, R., & Gribaldo, L. (2008) · Toxicology Letters · doi:10.1016/j.toxlet.2008.06.116 · Cited by 1
Cited by
Endocrine disrupting chemicals and disease susceptibility
Schug, T. T., Janesick, A., Blumberg, B., & Heindel, J. J. (2011) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2011.08.007 · Cited by 1,087
Self-citationA review on endocrine disruptors and their possible impacts on human health
Kabir, E. R., Rahman, M. S., & Rahman, I. (2015) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2015.06.009 · Cited by 945
Endocrine Disruptors: From Endocrine to Metabolic Disruption
Casals-Casas, C., & Desvergne, B. (2011) · Annual Review of Physiology · doi:10.1146/annurev-physiol-012110-142200 · Cited by 902
Bisphenol A exposure, effects, and policy: A wildlife perspective
Flint, S., Markle, T., Thompson, S., & Wallace, E. (2012) · Journal of Environmental Management · doi:10.1016/j.jenvman.2012.03.021 · Cited by 884
Developmental origins of non-communicable disease: Implications for research and public health
Barouki, R., Gluckman, P. D., Grandjean, P., Hanson, M., & Heindel, J. J. (2012) · Environmental Health · doi:10.1186/1476-069x-11-42 · Cited by 789
Metadata
- Authors
- Grün, F., & Blumberg, B.
- Venue
- Molecular and Cellular Endocrinology
- Publisher
- Elsevier BV
- Published
- 2009-05-25
- Volume
- 304
- Issue
- 1-2
- Pages
- 19-29
- ISSN
- 0303-7207 (ISSN-L)
- OpenAlex
- W2117923938
- Cited by
- 582
- References
- 248
- FWCI
- 24.83
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.